Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biomanufacturing
Manufacturing
Narcan ingredient maker Antheia reels in $56M series C funding
Narcan ingredient maker Antheia reeled in $56 million in series C financing it said will be used to expand manufacturing operations in the U.S.
Joseph Keenan
Jun 4, 2025 9:51am
Merck breaks ground on $1B Keytruda production site in Delaware
Apr 29, 2025 9:56am
Fujifilm Diosynth CEO marks 2025 as era of expansion execution
Jan 24, 2025 12:12pm
Future Fields unveils plant for fly-based protein production
Nov 12, 2024 9:00am
Samsung Biologics bags $1.2B production contract
Oct 22, 2024 10:02am
Bora's expansion tear continues as CDMO takes up stake in Tanvex
Aug 28, 2024 9:15am